Haferlach T - Search Results

1

Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemia.

Madan V, Shyamsunder P, Han L, Mayakonda A, Nagata Y, Sundaresan J, Kanojia D, Yoshida K, Ganesan S, Hattori N, Fulton N, Tan KT, Alpermann T, Kuo MC, Rostami S, Matthews J, Sanada M, Liu LZ, Shiraishi Y, Miyano S, Chendamarai E, Hou HA, Malnassy G, Ma T, Garg M, Ding LW, Sun QY, Chien W, Ikezoe T, Lill M, Biondi A, Larson RA, Powell BL, Lübbert M, Chng WJ, Tien HF, Heuser M, Ganser A, Koren-Michowitz M, Kornblau SM, Kantarjian HM, Nowak D, Hofmann WK, Yang H, Stock W, Ghavamzadeh A, Alimoghaddam K, Haferlach T, Ogawa S, Shih LY, Mathews V, Koeffler HP. Madan V, et al. Among authors: haferlach t. Leukemia. 2016 Aug;30(8):1672-81. doi: 10.1038/leu.2016.69. Epub 2016 Apr 11. Leukemia. 2016. PMID: 27063598 Free PMC article.

2

Clinical significance of CD95, Bcl-2 and Bax expression and CD95 function in adult de novo acute myeloid leukemia in context of P-glycoprotein function, maturation stage, and cytogenetics.

Wuchter C, Karawajew L, Ruppert V, Büchner T, Schoch C, Haferlach T, Ratei R, Dörken B, Ludwig WD. Wuchter C, et al. Among authors: haferlach t. Leukemia. 1999 Dec;13(12):1943-53. doi: 10.1038/sj.leu.2401605. Leukemia. 1999. PMID: 10602414

3

Screening for MLL tandem duplication in 387 unselected patients with AML identify a prognostically unfavorable subset of AML.

Schnittger S, Kinkelin U, Schoch C, Heinecke A, Haase D, Haferlach T, Büchner T, Wörmann B, Hiddemann W, Griesinger F. Schnittger S, et al. Among authors: haferlach t. Leukemia. 2000 May;14(5):796-804. doi: 10.1038/sj.leu.2401773. Leukemia. 2000. PMID: 10803509

4

Detection of acute leukemia cells with mixed lineage leukemia (MLL) gene rearrangements by flow cytometry using monoclonal antibody 7.1.

Wuchter C, Harbott J, Schoch C, Schnittger S, Borkhardt A, Karawajew L, Ratei R, Ruppert V, Haferlach T, Creutzig U, Dörken B, Ludwig WD. Wuchter C, et al. Among authors: haferlach t. Leukemia. 2000 Jul;14(7):1232-8. doi: 10.1038/sj.leu.2401840. Leukemia. 2000. PMID: 10914547

5

Double induction strategy including high dose cytarabine in combination with all-trans retinoic acid: effects in patients with newly diagnosed acute promyelocytic leukemia. German AML Cooperative Group.

Lengfelder E, Reichert A, Schoch C, Haase D, Haferlach T, Löffler H, Staib P, Heyll A, Seifarth W, Saussele S, Fonatsch C, Gassmann W, Ludwig WD, Hochhaus A, Beelen D, Aul C, Sauerland MC, Heinecke A, Hehlmann R, Wörmann B, Hiddemann W, Büchner T. Lengfelder E, et al. Among authors: haferlach t. Leukemia. 2000 Aug;14(8):1362-70. doi: 10.1038/sj.leu.2401843. Leukemia. 2000. PMID: 10942230 Clinical Trial.

6

Comparison of chromosome banding analysis, interphase- and hypermetaphase-FISH, qualitative and quantitative PCR for diagnosis and for follow-up in chronic myeloid leukemia: a study on 350 cases.

Schoch C, Schnittger S, Bursch S, Gerstner D, Hochhaus A, Berger U, Hehlmann R, Hiddemann W, Haferlach T. Schoch C, et al. Among authors: haferlach t. Leukemia. 2002 Jan;16(1):53-9. doi: 10.1038/sj.leu.2402329. Leukemia. 2002. PMID: 11840263

7

Karyotype instability between diagnosis and relapse in 117 patients with acute myeloid leukemia: implications for resistance against therapy.

Kern W, Haferlach T, Schnittger S, Ludwig WD, Hiddemann W, Schoch C. Kern W, et al. Among authors: haferlach t. Leukemia. 2002 Oct;16(10):2084-91. doi: 10.1038/sj.leu.2402654. Leukemia. 2002. PMID: 12357361

8

Pediatric acute lymphoblastic leukemia (ALL) gene expression signatures classify an independent cohort of adult ALL patients.

Kohlmann A, Schoch C, Schnittger S, Dugas M, Hiddemann W, Kern W, Haferlach T. Kohlmann A, et al. Among authors: haferlach t. Leukemia. 2004 Jan;18(1):63-71. doi: 10.1038/sj.leu.2403167. Leukemia. 2004. PMID: 14603332

9

New insights into MLL gene rearranged acute leukemias using gene expression profiling: shared pathways, lineage commitment, and partner genes.

Kohlmann A, Schoch C, Dugas M, Schnittger S, Hiddemann W, Kern W, Haferlach T. Kohlmann A, et al. Among authors: haferlach t. Leukemia. 2005 Jun;19(6):953-64. doi: 10.1038/sj.leu.2403746. Leukemia. 2005. PMID: 15815718

10

Genomic gains and losses influence expression levels of genes located within the affected regions: a study on acute myeloid leukemias with trisomy 8, 11, or 13, monosomy 7, or deletion 5q.

Schoch C, Kohlmann A, Dugas M, Kern W, Hiddemann W, Schnittger S, Haferlach T. Schoch C, et al. Among authors: haferlach t. Leukemia. 2005 Jul;19(7):1224-8. doi: 10.1038/sj.leu.2403810. Leukemia. 2005. PMID: 15902281

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

732 results

Search Page

Filters